Yalowich J C, Ross W E
Cancer Res. 1985 Apr;45(4):1651-6.
The effects of the calcium antagonist verapamil on the intracellular disposition of 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyra noside) (etoposide) (VP-16) as well as on subsequent DNA damage and cytotoxicity were studied in L1210 cells in vitro. At extracellular VP-16 concentrations of 1 to 5 microM, verapamil (10 microM) addition resulted in an increase of DNA single-strand break frequency comparable to that found when VP-16 was present alone at a 3-fold higher concentration. In addition, the elevation of cellular VP-16 levels in the presence of verapamil was linearly correlated with the enhancement of DNA damage and increased cell kill. Verapamil-mediated increase in net VP-16 transport was rapid (1 to 2 min), and allowed for the same elevation of steady-state VP-16 concentration, whether verapamil was added simultaneously with VP-16 or was added after a steady-state level of VP-16 was achieved. Verapamil-mediated elevation of VP-16 levels was not seen at reduced temperature (0 degrees C). Studies of bidirectional VP-16 transport revealed that verapamil (40 microM) did not alter influx of VP-16 (15 microM), but lowered the unidirectional rate constant for efflux by 93%, resulting in the observed increase of steady-state level of the epipodophyllotoxin. Removal of verapamil resulted in a rapid return of VP-16 to levels comparable to that seen with VP-16 alone. When VP-16 was allowed to flow out of the cell in the presence of verapamil, less than 5% of cellular epipodophyllotoxin was retained, suggesting that the calcium antagonist is not acting by enhancing intracellular binding of VP-16. These results indicate that verapamil potentiates VP-16 activity by elevation of intracellular exchangeable epipodophyllotoxin; an activity which seems to be due to inhibition of the efflux mechanism for VP-16. The low intracellular retention of this epipodophyllotoxin and the good correlation between intracellular VP-16 and subsequent DNA damage and cytotoxicity suggest that the epipodophyllotoxin class of anticancer agents may be more useful for probing calcium antagonist effects on drug transport in sensitive cells and in cells exhibiting pleiotropic drug resistance than the vinca alkaloids and anthracyclines which have large tight binding intracellular components.
在体外L1210细胞中研究了钙拮抗剂维拉帕米对4'-去甲基表鬼臼毒素-9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)(依托泊苷)(VP-16)细胞内分布以及随后的DNA损伤和细胞毒性的影响。在细胞外VP-16浓度为1至5微摩尔时,加入维拉帕米(10微摩尔)导致DNA单链断裂频率增加,这与单独存在浓度高3倍的VP-16时观察到的情况相当。此外,在维拉帕米存在下细胞内VP-16水平的升高与DNA损伤的增强和细胞杀伤增加呈线性相关。维拉帕米介导的VP-16净转运增加迅速(1至2分钟),并且无论维拉帕米是与VP-16同时添加还是在达到VP-16稳态水平后添加,都能使VP-16稳态浓度升高相同程度。在低温(0℃)下未观察到维拉帕米介导的VP-16水平升高。双向VP-16转运研究表明,维拉帕米(40微摩尔)不改变VP-16(15微摩尔)的内流,但使外向单向速率常数降低93%,导致观察到的表鬼臼毒素稳态水平增加。去除维拉帕米后,VP-16迅速恢复到与单独使用VP-16时相当的水平。当在维拉帕米存在下使VP-16流出细胞时,细胞内表鬼臼毒素保留不到5%,这表明钙拮抗剂不是通过增强VP-16的细胞内结合起作用。这些结果表明,维拉帕米通过提高细胞内可交换表鬼臼毒素的水平增强VP-16活性;这种活性似乎是由于抑制了VP-16的外排机制。这种表鬼臼毒素的低细胞内保留以及细胞内VP-16与随后的DNA损伤和细胞毒性之间的良好相关性表明,与具有大量紧密结合细胞内成分的长春花生物碱和蒽环类药物相比,表鬼臼毒素类抗癌药物可能更有助于探究钙拮抗剂对敏感细胞和表现出多药耐药性的细胞中药物转运的影响。